NFKB1 and posterior cortical atrophy: Therefore, the inhibition of USP8 might be a novel therapeutic target to inhibit PCa cell growth, proliferation, and metastasis and overcome docetaxel-mediated resistance in CRPC by suppressing EGFR, PI3K, and NF-kB signals.